We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

62 hedge funds and large institutions have $275M invested in Immune Design Corp. in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 3

386% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 7

31% more capital invested

Capital invested by funds: $210M → $275M (+$65.6M)

29% more funds holding

Funds holding: 4862 (+14)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
62
Holders Change
+14
Holders Change %
+29.17%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
34
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$1.09M +$936K +39,626 +299%
BIM
27
BlackRock Investment Management
Delaware
$948K +$658K +27,862 +154%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$873K +$462K +19,570 +86%
NFA
29
Nationwide Fund Advisors
Ohio
$767K +$292K +12,379 +50%
TCIM
30
TIAA CREF Investment Management
New York
$679K +$419K +17,727 +117%
TD Asset Management
31
TD Asset Management
Ontario, Canada
$646K +$399K +16,900 +117%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$427K +$223K +9,425 +84%
TA
33
Teachers Advisors
New York
$343K +$258K +10,917 +192%
Charles Schwab
34
Charles Schwab
California
$336K +$384K +16,243 New
BG
35
BlackRock Group
United Kingdom
$267K +$253K +10,694 +481%
SIM
36
Spark Investment Management
New York
$235K -$123K -5,200 -31%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$213K +$243K +10,300 New
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$178K +$204K +8,636 New
Swiss National Bank
39
Swiss National Bank
Switzerland
$145K +$165K +7,000 New
AIG
40
American International Group
New York
$137K +$66.2K +2,803 +73%
Wells Fargo
41
Wells Fargo
California
$109K +$114K +4,826 +983%
SO
42
STRS Ohio
Ohio
$107K +$123K +5,200 New
Morgan Stanley
43
Morgan Stanley
New York
$83K -$1.21M -51,226 -93%
FWM
44
Focused Wealth Management
New York
$70K -$11.9K -503 -13%
PAM
45
Panagora Asset Management
Massachusetts
$67K +$76.1K +3,222 New
Deutsche Bank
46
Deutsche Bank
Germany
$56K +$64K +2,710 +27,100%
Bank of America
47
Bank of America
North Carolina
$24K +$27.4K +1,158 +7,238%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$23K +$27.1K +1,146 New
TRCT
49
Tower Research Capital (TRC)
New York
$21K +$5.08K +215 +27%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$19.4K +$18.9K +799 +563%

IMDZ Hedge Fund Activity: Q2 2015 in Review

62 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q2 2015, worth a combined $275M — up 31% from $210M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new IMDZ positions and 3 closed out — a net gain of 14 holders — while 34 added to existing stakes and 7 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $17.6M. The largest seller was ProQuest Associates IV, cutting an estimated $10.2M.

  • 62 institutional investors held Immune Design Corp. (IMDZ) as of Q2 2015, up from 48 in Q1 2015.
  • Funds reported $275M of Immune Design Corp. stock for Q2 2015, up 31% quarter-over-quarter.
  • 17 funds opened new Immune Design Corp. positions in Q2 2015 and 3 closed out, a net change of +14 holders.
  • The largest Immune Design Corp. buyer in Q2 2015 was Sectoral Asset Management, an estimated $17.6M added.
  • The largest Immune Design Corp. seller in Q2 2015 was ProQuest Associates IV, an estimated $10.2M sold.

Based on aggregated 13F filings for Q2 2015.